<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05079464</url>
  </required_header>
  <id_info>
    <org_study_id>3348</org_study_id>
    <nct_id>NCT05079464</nct_id>
  </id_info>
  <brief_title>Exercise as a Primer for Brain Stimulation in Vascular Cognitive Impairment No Dementia (VCIND)</brief_title>
  <acronym>EXPRESS-V</acronym>
  <official_title>Exercise as a Primer for Excitatory Stimulation Study in Vascular Cognitive Impairment No Dementia (EXPRESS-V)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sunnybrook Health Sciences Centre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sunnybrook Health Sciences Centre</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      People with vascular conditions are at risk of having memory problems, and these memory&#xD;
      problems increase the risk for further cognitive decline. Brain stimulation has been used to&#xD;
      improve mood and memory. Transcranial direct current stimulation (tDCS) is believed to work&#xD;
      best on brain cells that are active or &quot;primed&quot; before stimulation. The purpose of this study&#xD;
      is to compare the effects of exercise and tDCS on memory performance in patients who have&#xD;
      completed cardiac rehabilitation and are at risk of cognitive decline.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Vascular disease is a major risk factor and contributor to dementia. Current interventions to&#xD;
      manage vascular risk factors have mixed results. Presently, there are no consistently&#xD;
      effective treatments targeting vascular cognitive impairment no dementia.&#xD;
&#xD;
      Study Aim: To evaluate the effect of exercise-primed tDCS on global cognition.&#xD;
&#xD;
      Study Design: Eligible participants will be randomized to one of four interventions: Exercise&#xD;
      primer with tDCS, Treatment as usual (TAU/exercise education) with tDCS, or Exercise primer&#xD;
      with sham tDCS, Treatment as usual with sham tDCS. Participants randomized to an exercise&#xD;
      group will undergo exercise, followed by either sham or active tDCS. Participants randomized&#xD;
      to TAU will receive written information in accordance with the Canadian Physical Activity&#xD;
      Guidelines for older adults and tDCS or sham. Cognition, behaviour, neuroimaging and blood&#xD;
      biomarkers will be measured.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">October 2021</start_date>
  <completion_date type="Anticipated">September 2024</completion_date>
  <primary_completion_date type="Anticipated">September 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized, blinded, repeated-session, parallel-design study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
    <masking_description>Participants, outcomes assessors, and investigators will be blinded to stimulation type.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Montreal Cognitive Assessment - Global Cognition</measure>
    <time_frame>2 weeks</time_frame>
    <description>The Montreal Cognitive Assessment is a 5-minute test of global cognition and a validated tool for detecting early cognitive changes.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cognitive domains</measure>
    <time_frame>2 weeks</time_frame>
    <description>Cognitive domains will be measured using the 60-minute battery recommended by the National Institute of Neurological Disorders and Stroke-Canadian Stroke Network.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Behavioural measures</measure>
    <time_frame>2 weeks</time_frame>
    <description>Behaviour will be measured with the Mild Behavioural Impairment-Checklist.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Vascular Cognitive Impairment</condition>
  <condition>Mild Cognitive Impairment</condition>
  <arm_group>
    <arm_group_label>Exercise primed tDCS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Individuals randomized to this group will receive exercise at University Health Network-Toronto Rehabilitation Institute followed by active tDCS.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Exercise primed Sham stimulation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Individuals randomized to this group will receive exercise at University Health Network-Toronto Rehabilitation Institute followed by sham tDCS.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment as usual (exercise education) &amp; tDCS</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Individuals randomized to this group will receive routine advice about physical activity, and active tDCS.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment as usual (exercise education) &amp; sham stimulation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Individuals randomized to this group will receive routine advice about physical activity, and sham tDCS.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>tDCS</intervention_name>
    <description>All participants randomized to tDCS will receive active tDCS</description>
    <arm_group_label>Exercise primed tDCS</arm_group_label>
    <arm_group_label>Treatment as usual (exercise education) &amp; tDCS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Exercise</intervention_name>
    <description>Participants will exercise at Toronto Rehab.</description>
    <arm_group_label>Exercise primed Sham stimulation</arm_group_label>
    <arm_group_label>Exercise primed tDCS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sham stimulation</intervention_name>
    <description>The same procedure for tDCS will be used for the sham condition, except without active current.</description>
    <arm_group_label>Exercise primed Sham stimulation</arm_group_label>
    <arm_group_label>Treatment as usual (exercise education) &amp; sham stimulation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Treatment as usual</intervention_name>
    <description>Exercise education/ treatment as usual will include routine advice about physical activity.</description>
    <arm_group_label>Treatment as usual (exercise education) &amp; sham stimulation</arm_group_label>
    <arm_group_label>Treatment as usual (exercise education) &amp; tDCS</arm_group_label>
    <other_name>Exercise education</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ≥50 years of age; females must be post-menopausal&#xD;
&#xD;
          -  Presence of cerebrovascular and/or cardiovascular risk factors or coronary artery&#xD;
             disease&#xD;
&#xD;
          -  Montreal Cognitive Assessment (MoCA) &lt;27&#xD;
&#xD;
          -  Sufficiently proficient in English&#xD;
&#xD;
          -  Must be able to exercise at a moderate intensity level&#xD;
&#xD;
          -  Presence of modest deficits (1 standard deviation below population norm) in one of the&#xD;
             following domains: executive function, verbal memory, working memory, or visuospatial&#xD;
             memory&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of stroke&#xD;
&#xD;
          -  Change in psychotropics within the last 4 weeks&#xD;
&#xD;
          -  Current benzodiazepine use due&#xD;
&#xD;
          -  Metal implants that would preclude safe use of tDCS or neuroimaging&#xD;
&#xD;
          -  Significant neurological or psychiatric conditions (current major depressive disorder,&#xD;
             bipolar disorder, schizophrenia)&#xD;
&#xD;
          -  MoCA &lt;18 and/or clinical diagnosis of dementia&#xD;
&#xD;
          -  Any medical contraindications to exercise&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Krista Lanctôt, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sunnybrook Research Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mehreen Siddiqui</last_name>
    <phone>416-480-6100</phone>
    <phone_ext>63185</phone_ext>
    <email>mehreen.siddiqui@sri.utoronto.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Vivian Feng</last_name>
    <phone>416-480-6100</phone>
    <phone_ext>63185</phone_ext>
    <email>vivian.feng@sri.utoronto.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sunnybrook Health Sciences Centre</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M4N 3M5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mehreen Siddiqui</last_name>
      <phone>416-480-6100</phone>
      <phone_ext>63185</phone_ext>
      <email>mehreen.siddiqui@sri.utoronto.ca</email>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 16, 2021</study_first_submitted>
  <study_first_submitted_qc>October 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 15, 2021</study_first_posted>
  <last_update_submitted>October 12, 2021</last_update_submitted>
  <last_update_submitted_qc>October 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>transcranial direct current stimulation</keyword>
  <keyword>tDCS</keyword>
  <keyword>exercise</keyword>
  <keyword>cognition</keyword>
  <keyword>vascular cognitive impairment no dementia</keyword>
  <keyword>vascular mild cognitive impairment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dementia</mesh_term>
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

